[Phase II trial of mitoguazone in patients with recurrent extensive cervicofacial tumors].
D000328:Adult; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D004341:Drug Evaluation; D005153:Facial Neoplasms / Q000188:drug therapy*; D006146:Guanidines / Q000627:therapeutic use*; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008935:Mitoguazone / Q000627:therapeutic use*; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*
D006146:Guanidines; D008935:Mitoguazone
Essai phase II de mitoguazone chez des patients porteurs de tumeurs cervico-faciales étendues en récidive.